Suk Ran Yoon Selected Research

Hypoxia (Hypoxemia)

1/2011	Thymosin β4 expression correlates with lymph node metastasis through hypoxia inducible factor-α induction in breast cancer.
5/2008	VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway.
2/2008	Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suk Ran Yoon Research Topics

Disease

28	Neoplasms (Cancer) 02/2024 - 07/2003
9	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2008
6	Stomach Neoplasms (Stomach Cancer) 10/2017 - 07/2003
3	Breast Neoplasms (Breast Cancer) 09/2022 - 01/2011
3	Inflammation (Inflammations) 01/2022 - 10/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 04/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2016 - 08/2007
3	Shock 08/2015 - 11/2012
3	Hypoxia (Hypoxemia) 01/2011 - 02/2008
2	Endometriosis 04/2023 - 10/2014
2	Carcinoma (Carcinomatosis) 12/2022 - 12/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2006
2	Obesity 01/2022 - 12/2017
2	Sepsis (Septicemia) 01/2022 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 07/2020 - 05/2014
2	Thyroid Neoplasms (Thyroid Cancer) 06/2019 - 01/2018
2	Carcinogenesis 01/2017 - 07/2003
2	Leukemia 11/2016 - 05/2014
1	Thrombocytopenia (Thrombopenia) 12/2023
1	Melanoma (Melanoma, Malignant) 12/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Male Infertility (Male Sterility) 06/2021
1	Body Weight (Weight, Body) 06/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018
1	Mucositis 01/2018
1	Anaplastic Thyroid Carcinoma 01/2018
1	Insulin Resistance 12/2017

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2008
8	ThioredoxinsIBA 12/2023 - 04/2010
7	CytokinesIBA 04/2023 - 10/2012
4	Therapeutic UsesIBA 06/2021 - 10/2012
3	LigandsIBA 01/2023 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2020 - 03/2009
3	Small Interfering RNA (siRNA)IBA 04/2014 - 12/2007
2	Phosphotransferases (Kinase)IBA 02/2024 - 07/2020
2	rho Guanine Nucleotide Dissociation Inhibitor alphaIBA 02/2024 - 01/2018
2	Peptides (Polypeptides)IBA 01/2022 - 12/2018
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 05/2020 - 01/2018
2	fludarabineIBA 11/2018 - 05/2014
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 07/2003
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018 - 10/2012
2	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2017 - 01/2017
2	NF-kappa B (NF-kB)IBA 01/2017 - 02/2008
2	Auranofin (Ridaura)FDA Link 01/2017 - 01/2017
2	Salivary CystatinsIBA 01/2017 - 01/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015 - 01/2013
2	InflammasomesIBA 08/2015 - 01/2013
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2015 - 01/2013
2	LipopolysaccharidesIBA 08/2015 - 01/2013
2	Granzymes (Granzyme)IBA 02/2015 - 10/2014
2	Interleukin-18 (Interleukin 18)IBA 02/2013 - 02/2008
2	Cholecalciferol (Vitamin D3)FDA Link 04/2010 - 05/2008
1	Polo-Like Kinase 1IBA 02/2024
1	Interleukin-17 (Interleukin 17)IBA 04/2023
1	Actins (F Actin)IBA 01/2023
1	ChemokinesIBA 12/2022
1	Adenosine Triphosphatases (ATPase)IBA 09/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	fructus aurantii immaturusIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2022
1	AntigensIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2021
1	Semaphorin-3AIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2019
1	KynurenineIBA 06/2019
1	p38 Mitogen-Activated Protein KinasesIBA 12/2018
1	Blood Glucose (Blood Sugar)IBA 12/2018
1	ProstaglandinsIBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	Death Domain ReceptorsIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018
1	ginsenoside Rg3IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Docetaxel (Taxotere)FDA Link 10/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017

Therapy/Procedure

7	Therapeutics 09/2022 - 07/2011
4	Immunotherapy 01/2023 - 08/2007
2	Cell Transplantation 01/2023 - 11/2016
2	Transplantation 11/2016 - 05/2014
1	Traditional Medicine (Folk Remedies) 01/2022
1	Radiotherapy 01/2021
1	Punctures 01/2019
1	Ligation 01/2019
1	Drug Therapy (Chemotherapy) 10/2017